Skip to main content
TipRanks
Go Ultimate75% OFF

NKGen Biotech (NKGN) Stock Statistics & Valuation Metrics

123 Followers

Total Valuation

NKGen Biotech has a market cap or net worth of $391.81K. The enterprise value is $46.02T.

Market Cap
$391.81K
Enterprise Value
$46.02T

Share Statistics

NKGen Biotech has 130,602,230 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
130,602,230
Owned by Insiders
―
Owned by Institutions
2.11%

Financial Efficiency

NKGen Biotech’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is -112358.33%.

Return on Equity (ROE)
0.00
Return on Assets (ROA)
-1845.25
Return on Invested Capital (ROIC)
-112358.33%
Return on Capital Employed (ROCE)
-1123.58
Revenue Per Employee
0
Profits Per Employee
-1.70M
Employee Count
26
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of NKGen Biotech is -0.00. NKGen Biotech’s PEG ratio is -0.00.

PE Ratio
-0.00
PS Ratio
0.00
PB Ratio
0.00
Price to FCF
-0.02
Price to Operating Cash Flow
-0.00
PEG Ratio
-0.00

Income Statement

In the last 12 months, NKGen Biotech had revenue of 0 and earned -44.29M in profits. Earnings per share was -1.54.

Revenue
0
Gross Profit
0
Operating Income
-26.97M
Pretax Income
-44.23M
Net Income
-44.29M
EBITDA
-40.19M
Earnings Per Share (EPS)
-1.54

Cash Flow

In the last 12 months, operating cash flow was -19.65M and capital expenditures -52,000, giving a free cash flow of -19.70M billion.

Operating Cash Flow
-19.65M
Free Cash Flow
-19.70M
Free Cash Flow per Share
-0.72

Dividends & Yields

NKGen Biotech pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-5329.41%
Earnings Yield
-51202.98%

Stock Price Statistics

Beta
-0.02
52-Week Price Change
-47.62%
50-Day Moving Average
0.02
200-Day Moving Average
0.06
Relative Strength Index (RSI)
15.32
Average Volume (3m)
5,410

Financial Position

NKGen Biotech as a current ratio of 0.00, with Debt / Equity ratio of 0.00%

Current Ratio
0.00
Quick Ratio
0.00
Debt to Market Cap
0.00
Net Debt to EBITDA
0.00
Interest Coverage Ratio
-9.90

Taxes

In the past 12 months, NKGen Biotech has paid 53.00K in taxes.

Income Tax
53.00K
Effective Tax Rate
-0.00

Enterprise Valuation

NKGen Biotech EV to EBITDA ratio is -0.01, with an EV/FCF ratio of -0.02.

EV to Sales
0.00
EV to EBITDA
-0.01
EV to Free Cash Flow
-0.02
EV to Operating Cash Flow
-0.02

Balance Sheet

NKGen Biotech has $6,000.00 in cash and marketable securities with $38.19M in debt, giving a net cash position of -$38.19M billion.

Cash & Marketable Securities
$6,000.00
Total Debt
$38.19M
Net Cash
-$38.19M
Net Cash Per Share
-$0.29
Tangible Book Value Per Share
-$1.75

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for NKGen Biotech is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
0
Revenue Growth Forecast
―
EPS Growth Forecast
―